Clinical Trial Update: Phase 1b/2 Study of Liposomal Annamycin (L-Annamycin) in Subjects With Previously Treated Soft-Tissue Sarcomas (STS) With Pulmonary Metastases [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1b/2 clinical trial evaluating liposomal annamycin in patients with soft tissue sarcoma and pulmonary metastases; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Metastasis
• Soft Tissue Sarcoma

Drugs mentioned

• liposomal annamycin (L-Annamycin) (liposomal annamycin)

Snippet

Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology | Conditions: Soft Tissue Sarcoma, Pulmonary Metastasis | Phase 1, Phase 2 | Status: UNKNOWN